Invesco S&P 500 Equal Weight Health Care ETF (RSPH) Covered Calls

Invesco S&P 500 Equal Weight Health Care ETF provides exposure to the healthcare sector of the S&P 500 using an equal-weighting methodology. Unlike traditional market-cap funds, it assigns an identical weight to each constituent, reducing concentration risk from mega-cap companies. The fund covers a broad spectrum of industries, including biotechnology, pharmaceuticals, and medical devices, offering a more balanced participation in the growth of mid- and large-cap healthcare stocks.

You can sell covered calls on Invesco S&P 500 Equal Weight Health Care ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RSPH (prices last updated Wed 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

The Invesco S&P 500 Equal Weight Health Care ETF is a strategic investment tool designed for those who want broad exposure to the medical sector without the heavy concentration typically found in market-cap-weighted indices. By tracking the S&P 500 Equal Weight Health Care Index, the fund ensures that every healthcare company in the S&P 500 has an equal impact on the portfolio performance at each quarterly rebalance. This approach provides a unique "size-factor" tilt toward mid-sized healthcare firms.

Core Business and Products

The primary product of this fund is a diversified equity portfolio of approximately 60 healthcare stocks. Because of its equal-weighting mandate, the fund gives as much prominence to specialized biotech firms as it does to pharmaceutical giants. This leads to higher exposure in sub-sectors like healthcare equipment and supplies compared to traditional funds. Key holdings within the fund include innovative companies such as Moderna, DaVita, and Viatris.

The fund also captures the performance of diversified healthcare services and diagnostic tools. Major constituents include Gilead Sciences, Bristol-Myers Squibb, and Amgen. By maintaining this balance, the fund avoids the risk of a few mega-cap stocks dominating the return profile. The fund is particularly useful for investors who believe that the broader healthcare sector, rather than just its largest players, will drive future medical innovation and shareholder value.

Competitive Landscape

The fund competes primarily with market-cap-weighted sector funds and other "smart beta" healthcare products. Its most formidable rival is the Health Care Select Sector SPDR Fund, which is significantly larger and more liquid but heavily concentrated in its top holdings. Other major competitors include the Vanguard Health Care ETF and the iShares U.S. Healthcare ETF, both of which follow more traditional weighting methods.

Within the equal-weight space, the fund stands out for its deep history (previously trading under the ticker RYH) and its institutional pedigree. It also competes for capital with the SPDR S&P Biotech ETF, which focuses more narrowly on the high-volatility biotechnology sub-sector. While the fund includes giants like Johnson & Johnson, their influence is capped, making the fund’s performance distinct from these competitors when large-cap stocks underperform the broader sector.

Strategic Outlook and Innovation

The strategic focus of the fund is to provide a "pure-play" healthcare exposure that benefits from the mean-reversion and diversification benefits of equal-weighting. Innovation in the portfolio is driven by the underlying companies, which are currently pioneering advancements in gene therapy, robotic surgery, and personalized oncology. The quarterly rebalancing process acts as a built-in "buy low, sell high" mechanism, as the fund sells stocks that have outperformed and buys those that have underperformed to restore equal weights.

The long-term outlook is supported by a global environment characterized by aging populations and an increasing focus on healthcare efficiency. The fund is well-positioned to capture the growth of healthcare providers and distributors as they integrate digital health solutions and artificial intelligence into patient care. By offering a balanced, evergreen exposure to the scientific and industrial leaders of the S&P 500 healthcare sector, the fund provides a resilient alternative for investors seeking to capture the total breadth of medical progress.

Want more examples? RSPD Covered Calls | RSPN Covered Calls